The traditional narrative of hot flushes, irritability, dryness and mood swings associated with menopause is true but incomplete. In 2026, the clinical lens has widened significantly, supported by a growing body of research. We must now recognise menopause as less a story of the ovaries and more a complex saga of the nervous system.
This phase is a neurological transition that reshapes a woman’s cognitive architecture, emotional resilience and sensory perception for the remainder of her life—often spanning one-third to one-half of her lifespan, depending on the age at menopause.
It is a time when, although most women remain biologically anchored to oestrogen and progesterone, the hormonal reality is far more expansive. During this phase, the body undergoes a systemic recalibration involving over 18 hormones, including insulin, cortisol, DHEA, melatonin and thyroid hormones. These shifts occur at the mitochondrial level, fundamentally reprogramming cellular metabolism and energy production. The ripple effects of this recalibration impact nearly the entire physiology, with the brain and bones bearing the greatest burden.
One day in 2016, I received a call from an inpatient ward where I was working as a pathologist, requesting me to perform a lumbar puncture on a 61-year-old patient, Anita. When I pulled back the curtain, I saw an elegant woman who appeared to be in her forties, seated with her adolescent children beside her.
Anita was watching something on her phone. When I greeted her, she looked up and, as I attempted small talk, I began to understand the true reason for my visit.
She took an unusually long time to grasp simple words. Her eyes remained attentive, straining to receive language before going blank for a while as she started processing the words. I could see the effort it took for her to form the words on her lips; her facial muscles twitched as she spoke slowly. Her daughter stepped forward to help communicate. Both children looked exhausted—a deep fatigue in their eyes that no amount of sleep could restore. They described how their mother now needed assistance with communication and basic tasks such as eating, brushing her teeth and dressing.
Her bedside file noted atypical dementia with coarse tremors and suspected Alzheimer’s disease. Her scans revealed brain atrophy. The history recorded her age at menopause as 37. So, here stood a striking case of premature menopause accompanied by severe cognitive decline. Her blood work revealed markedly fluctuating and depleted reproductive and other hormone levels.
In India, the average age of menopause is 45-46 years—significantly earlier than the global average of 51. This earlier onset creates a wider “vulnerability window”, during which multi-system risks emerge while women are often at the peak of their professional and familial responsibilities. Premature menopause occurring in the 30s or early 40s further amplifies these risks.
Today, we have sufficient data to map menopause through meaningful graphs and trends that clearly highlight critical “red flag” patterns. Several landmark studies from the past decade reinforce this:
• The cardiac surge: Research published in JAMA Cardiology indicates that women with premature menopause face a 40 per cent higher lifetime risk of coronary heart disease. The loss of oestrogen’s cardioprotective effect exposes the vascular system—and the brain it nourishes—to damage. This transition also drives an independent rise in LDL cholesterol and arterial stiffness.
• The heart-brain connection: Studies demonstrate that higher cardiovascular risk in menopausal women is directly associated with increased cognitive decline and dementia risk.
• The auditory link: Emerging data from the UK Biobank highlights that hearing loss in midlife is a powerful accelerator of cognitive decline. Oestrogen receptors play a key role in cochlear health; their decline can impair auditory processing.
The Lancet Commission identifies hearing loss as the single largest modifiable risk factor for dementia.
• The cognitive toll: Nearly two-thirds of Alzheimer’s patients are women. This reflects biology, not coincidence. Once early cognitive decline begins, 10-15 per cent of cases progress to clinical dementia each year. Women today are no longer defenceless against this “neurological cliff”. Biomarkers such as beta-amyloid and phosphorylated tau can now detect Alzheimer’s pathology up to a decade before clinical symptoms appear—well before structural changes are visible on imaging.
The therapeutic landscape is also evolving. Anti-amyloid therapies are being introduced in India, offering a means to clear protein plaques that drive neurodegeneration. Menopause represents a fully matured phase of life—one that should be defined by vitality and wisdom, not decline. Evidence suggests that initiating Hormone Replacement Therapy (HRT) within the first five years after menopause, in carefully selected individuals, can reduce the risk of major coronary disease by up to 44 per cent.
A significant global shift has also occurred: the FDA has reframed HRT as Menopausal Replacement Therapy (MRT) and updated safety labels by removing longstanding warnings related to cardiovascular disease, breast cancer and probable dementia. These warnings had significantly reduced HRT usage for over two decades. The revised guidance now enables more nuanced, individualised clinical decision-making.
Women in perimenopause must remain vigilant about cognitive and sensory health. I often hear women—even doctors—say, “My menopause is over.”
Biologically, this is a misconception. What follows is not resolution, but adaptation to a lower hormonal baseline.
While symptoms may subside, adjusting to this new normal, the loss of hormonal protection for the cardiovascular and nervous systems, is a life-long process. By recognising menopause as a multi-system transition and adopting preventive strategies, we can preserve identity, cognition and vitality. Menopause is not a decline—it is a neurological transition. To ignore it is to overlook one of the most significant, silent drivers of cognitive decline in modern times.